Researchers at Northwestern University developed a nanoparticle delivery system for a common immunosuppressant drug that increases the potential of pancreatic islet transplantation as a viable long-term treatment for Type I diabetes. The technology targets the drug to act on the antigen presenting cells of the immune system, rather than T cells. Th (Read more...)
Tag: diabetes
Sufferers of both Type 2 diabetes and sleep apnoea could lose eyesight within four years
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to…
Sufferers of both Type 2 diabetes and sleep apnoea could lose eyesight within four years
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to…
Diabetes doctors: Which specialists treat diabetes?
There are a variety of healthcare professionals that can help manage diabetes. Knowing what to expect from each will help you make the most of your visit.
Youth with type 2 diabetes develop complications more often than type 1 peers
Teens and young adults with type 2 diabetes develop kidney, nerve, and eye diseases – as well as some risk factors for heart disease – more often than their peers with type 1 diabetes in the years…
Sedentary behavior associated with diabetic retinopath
In a study published online by JAMA Ophthalmology, Paul D. Loprinzi, Ph.D., of the University of Mississippi, University, Miss.
Could restoring electrical signals help heal diabetic wounds?
Mouse study finds cornea wounds in diabetes have abnormal electric signals and suggests they could be a target in managing slow and non-healing wounds.
Researchers discover heart drug could reduce diabetes related blindness
Researchers at Queen’s University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes…
High-priced drugs used to treat diabetic macular edema not cost-effective
The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular edema (DME), and approximately 20 to 30 times more expensive than…
Eye study underscores the long-lasting benefits of controlling diabetes
People with type 2 diabetes who intensively controlled their blood sugar level during the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study were found to have cut…
Blurry Vision and Diabetes: What’s the Connection?
Diabetes can cause blurry vision for many reasons. Learn about the short-term and long-term complications that can affect vision in people with diabetes.
Researchers identify candidate biomarker of accelerated onset diabetic retinopathy
Mass. Eye and Ear researchers describe, for the first time, an association between a defective myogenic response of blood vessels in the retina and early, accelerated development of retinopathy in…
Researchers discover a genetic mutation that prevents diabetes complications
A number of complications are associated with diabetes, but they are more prevalent in some patients than in others.
New risk tools spot patients at high risk of diabetes complications
Two new risk prediction tools can identify patients with diabetes who are at high risk of blindness and amputation – two serious complications of diabetes, finds a study published in The BMJ this…
New study shows that ranibizumab used in a treat-and-extend regimen cuts clinic visits by 46% for patients with Diabetic Macular Oedema
Data from a new study shows that ranibizumab (Lucentis®) used in a treat-and-extend (T&E) regimen cuts clinic visits by 46% for patients with Diabetic Macular Oedema (DMO) – one of the leading…
Diabetic retinopathy screening for children with type 1 diabetes should start later
A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their…
New discovery provides insight into the development of complications in type 1 diabetes
Findings by Joslin researchers may lead to early detection and treatment of complicationsJoslin scientists have advanced understanding of how the cellular repair process is impaired in type 1…
Diabetic blindness: UVA IDs best source of stem cells to block vision loss
Evaluation a key step in creation of treatment for disease that affects millionsUniversity of Virginia School of Medicine researchers have taken a significant step forward in their efforts to use…
NICE recommends EYLEA for visual impairment due to diabetic macular oedema (DMO)
The National Institute for Health and Care Excellence (NICE) draft Final Appraisal Determination (FAD) recommends EYLEA for the treatment of patients with visual impairment due to diabetic macular…
Metformin use associated with reduced risk of developing open-angle glaucoma
Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study…